Anti-Influenza Virus-Specific Nasal Secretory IgA and Serum IgG Titers in a Japanese Adult Population and their Changes after Subcutaneous Vaccination-Reference-Cited by-同舟云学术

Anti-Influenza Virus-Specific Nasal Secretory IgA and Serum IgG Titers in a Japanese Adult Population and their Changes after Subcutaneous Vaccination

Published:2021-07-20 Issue:7 Volume:124 Page:987-997
ISSN:0030-6622
Container-title:Nippon Jibiinkoka Gakkai Kaiho
language:en
Short-container-title:Nippon Jibiinkoka Gakkai Kaiho

Author:

Fujimoto Chisa¹,Yanagawa Hiroaki²,Sawabuchi Takako³,Kido Hiroshi³,Takeda Noriaki⁴

Affiliation:

1. Anan Medical Center

2. Center of IRB, Tokushima University Hospital

3. Division of Enzyme Chemistry, Institute for Enzyme Research, The University of Tokushima

4. Department of Otolaryngology-Head and Neck Surgery, The University of Tokushima Graduate School

Publisher

Oto-Rhino-Laryngological Society of Japan, Inc.

Subject

Otorhinolaryngology

Link

https://www.jstage.jst.go.jp/article/jibiinkoka/124/7/124_987/_pdf

Reference20 articles.

1. 1) Holmgren J, Czerkinsky C: Mucosal immunity and vaccines. Nat Med 2005; 11(Suppl): S45-53.

2. 2) Tamura S, Kurata T: Defense mechanisms against influenza virus infection in the respiratory tract mucosa. Jpn J Infect Dis 2004; 57: 236-247.

3. 3) Mizuno D, Ide-Kurihara M, Ichinomiya T, et al: Modified pulmonary surfactant is a potent adjuvant that stimulates the mucosal IgA production in response to the influenza virus antigen. J Immunol 2006; 176: 1122-1130.

4. 4) Mizuno D, Kimoto T, Sakai S, et al: Induction of systemic and mucosal immunity and maintenance of its memory against influenza A virus by nasal vaccination using a new mucosal adjuvant SF-10 derived from pulmonary surfactant in young cynomolgus monkeys. Vaccine 2016; 34: 1881-1888.

5. 5) Shvartsman YS, Agranovskaya EN, Zykov MP: Formation of secretory and circulating antibodies after immunization with live and inactivated influenza virus vaccines. J Infect Dis 1977; 135: 697-705.